Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Relapsed or Refractory IDH1 Mutation-Positive Acute Myeloid Leukemia
Tokyo and Other Japanese Cities
Relapsed or Refractory IDH1 Mutation-Positive Acute Myeloid Leukemia Clinical Trials in Tokyo and Other Japanese Cities
1 recruiting
Tokyo and Other Japanese Cities, Japan
Showing
1–1
of
1
trials
Recruiting
Phase 2
A Clinical Trial of Olutasidenib in Patients With Acute Myeloid Leukemia
Relapsed or Refractory IDH1 Mutation-Positive Acute Myeloid Leukemia
Kissei Pharmaceutical Co., Ltd.
3 enrolled
1 location
NCT07604064
Feedback